Arcutis Biotherapeutics, Inc.
ARQT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787306
In the last 90 days, Arcutis Biotherapeutics, Inc. insiders filed 0 open-market purchases and 12 sales; 272 institutions reported holding it in 13F filings for Q2 2026, worth $3.45B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Arcutis Biotherapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 144
- +3 vs. Q4 2022
- Shares held
- 71.6M
- +5.49M (+8.3%) vs. Q4 2022
- Total value
- $787.6M
- −$192.0M (−19.6%) vs. Q4 2022
- New holders
- 23
- 68 more added
- Sold out
- 20
- 32 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARQT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 272 | $3.45B |
| Q1 2026 | 270 | $3.12B |
| Q4 2025 | 283 | $3.75B |
| Q3 2025 | 239 | $2.37B |
| Q2 2025 | 230 | $1.78B |
| Q1 2025 | 241 | $1.97B |
| Q4 2024 | 208 | $1.79B |
| Q3 2024 | 188 | $1.20B |
| Q2 2024 | 186 | $1.18B |
| Q1 2024 | 168 | $1.24B |
| Q4 2023 | 133 | $327.1M |
| Q3 2023 | 134 | $356.7M |
| Q2 2023 | 136 | $684.0M |
| Q1 2023 | 144 | $787.6M |
| Q4 2022 | 141 | $979.6M |
| Q3 2022 | 139 | $1.13B |
| Q2 2022 | 115 | $1.05B |
| Q1 2022 | 106 | $929.8M |
| Q4 2021 | 93 | $961.8M |
| Q3 2021 | 103 | $1.09B |
| Q2 2021 | 102 | $1.24B |
| Q1 2021 | 94 | $1.35B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Arcutis Biotherapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Centiva Capital, LP | 200,000 | $2.20M | 0.12% | +200,000 | New |
| 1492 Capital Management LLC | 223,516 | $2.46M | 1.52% | +48,970+28.1% | Added |
| Parallax Volatility Advisers, L.P. | 226,313 | $2.49M | 0.09% | +163,137+258.2% | Added |
| Citigroup Inc | 243,999 | $2.68M | 0.00% | +110,771+83.1% | Added |
| Goldman Sachs Group Inc | 246,976 | $2.72M | 0.00% | −32,689−11.7% | Reduced |
| MPM Oncology Impact Management LP | 254,137 | $2.80M | 0.73% | −7,932−3.0% | Reduced |
| Citadel Advisors LLC | 271,521 | $2.99M | 0.00% | +261,888+2,718.7% | Added |
| SEI Investments Co | 273,599 | $3.01M | 0.01% | +273,599 | New |
| Charles Schwab Investment Management Inc | 302,502 | $3.33M | 0.00% | +774+0.3% | Added |
| Rafferty Asset Management, LLC | 304,706 | $3.35M | 0.02% | +1,577+0.5% | Added |
| Sectoral Asset Management Inc | 317,152 | $3.49M | 0.67% | +113,300+55.6% | Added |
| Morgan Stanley | 337,654 | $3.71M | 0.00% | +139,590+70.5% | Added |
| Northern Trust Corp | 386,861 | $4.26M | 0.00% | +2,009+0.5% | Added |
| EcoR1 Capital, LLC | 415,322 | $4.57M | 0.15% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 438,115 | $4.82M | 0.00% | +67,625+18.3% | Added |
| AXA S.A. | 442,479 | $4.87M | 0.02% | +106,693+31.8% | Added |
| Ensign Peak Advisors, Inc | 486,240 | $5.35M | 0.01% | +1,688+0.3% | Added |
| Opaleye Management Inc. | 502,000 | $5.52M | 1.65% | +502,000 | New |
| American Century Companies Inc | 508,019 | $5.58M | 0.00% | −72,870−12.5% | Reduced |
| Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $6.26M | 2.58% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 679,391 | $7.47M | 0.36% | +679,391 | New |
| Woodline Partners LP | 695,675 | $7.65M | 0.11% | +50,776+7.9% | Added |
| Geode Capital Management, LLC | 808,367 | $8.89M | 0.00% | +29,223+3.8% | Added |
| Ameriprise Financial Inc | 854,734 | $9.40M | 0.00% | +41,112+5.1% | Added |
| Allspring Global Investments Holdings, LLC | 1,114,111 | $12.3M | 0.02% | +47,260+4.4% | Added |
| Barclays PLC | 1,330,065 | $14.6M | 0.02% | +149,681+12.7% | Added |
| Franklin Resources Inc | 1,593,370 | $17.5M | 0.01% | +795,634+99.7% | Added |
| Bank of America Corp | 1,621,774 | $17.8M | 0.00% | +1,382,736+578.5% | Added |
| Avidity Partners Management LP | 1,628,500 | $17.9M | 0.59% | −126,500−7.2% | Reduced |
| Pictet Asset Management SA | 1,656,065 | $18.2M | 0.02% | +17,132+1.0% | Added |
| GW&K Investment Management, LLC | 1,904,722 | $21.0M | 0.20% | +352,708+22.7% | Added |
| OrbiMed Advisors LLC | 1,914,479 | $21.1M | 0.42% | −545,629−22.2% | Reduced |
| Holocene Advisors, LP | 2,069,177 | $22.8M | 0.11% | +924,034+80.7% | Added |
| Jennison Associates LLC | 2,214,490 | $24.4M | 0.02% | +816,211+58.4% | Added |
| Marshall Wace, LLP | 2,305,336 | $25.4M | 0.06% | +2,305,336 | New |
| Vanguard Group Inc | 2,582,131 | $28.4M | 0.00% | +50,719+2.0% | Added |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $33.0M | 4.12% | 00.0% | Unchanged |
| Polar Capital Holdings Plc | 3,135,513 | $34.5M | 0.25% | +1,129,736+56.3% | Added |
| Rubric Capital Management LP | 3,500,000 | $38.5M | 1.53% | +757,481+27.6% | Added |
| State Street Corp | 3,614,781 | $39.8M | 0.00% | −64,604−1.8% | Reduced |
| BlackRock Inc. | 4,598,272 | $50.6M | 0.00% | −615,986−11.8% | Reduced |
| Frazier Life Sciences Management, L.P. | 8,684,232 | $95.5M | 6.92% | 00.0% | Unchanged |
| FMR LLC | 9,162,430 | $100.8M | 0.01% | +23,257+0.3% | Added |
| Mirabella Financial Services LLP | 45,299 | – | – | +45,299 | New |
| Logos Global Management LP | 0 | $0 | 0.00% | −1,400,000−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1,103,576−100.0% | Sold out |
| Westfield Capital Management Co LP | 0 | $0 | 0.00% | −680,374−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −664,447−100.0% | Sold out |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −650,000−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −190,818−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −145,336−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −84,022−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −65,995−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −36,227−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −28,100−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −15,972−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −14,500−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −13,900−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −13,739−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −12,222−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −10,521−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −10,379−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −585−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −480−100.0% | Sold out |